Overstaging of the mesorectal fascia following neoadjuvant therapy and its impact on therapeutic management: a single-center retrospective cohort study of 506 mesorectal fascia positive patients
Authors:
- Xiao HuangXHXiao Huang
- Tianan GuoTGTianan Guo
- Huan ZhangHZHuan Zhang
- Yiwei ZengYZYiwei Zeng
- Dan HuangDHDan Huang
- Tong TongTTTong Tong
- Ye XuYXYe Xu
Open Access
- 1 February 2026
- journal article
- Published by AME Publishing Company in Journal of Gastrointestinal Oncology
- Vol. 17 (1) , 11
Abstract
Background: Accurate assessment of mesorectal fascia (MRF) involvement status after neoadjuvant therapy (NAT) is critical for guiding post-NAT treatment. However, the discordance between magnetic resonance imaging (MRI)-based evaluations and histopathological results may drive overtreatment and complicate organ-preservation strategies. This study aimed to evaluate the association between post-NAT MRF involvement and pathological circumferential resection margin (CRM) positivity. Methods: This retrospective cohort study included treatment-naïve rectal cancer patients with MRI-confirmed MRF involvement between January 2014 and January 2024. All patients underwent MRI restaging after the NAT. The diagnostic performance, including sensitivity and specificity, of MRI-assessed MRF status was assessed to determine its efficacy in predicting pathological CRM positivity. Logistic regression and mixed-effects models were used to quantify the association between MRF status and CRM positivity. Cox regression analysis was used to assess the effect of MRF positivity on survival outcomes. Results: Among 506 enrolled patients, restaging MRI showed persistent MRF involvement in 50.2% (254/506). The CRM-positive rate was 10.2% in the MRF-positive group, compared to 1.6% in the MRF-negative group. Concordance between MRI and pathological assessment was poor (sensitivity: 0.867, specificity: 0.521, Kappa: 0.086). Nevertheless, MRF positivity independently predicted CRM positivity [odds ratio (OR): 6.228, 95% confidence interval (CI): 2.349–21.507, Pvs. 0.59; 3-year: 0.66 vs. 0.58; 5-year: 0.75 vs. 0.63]. Conclusions: MRI assessment of MRF involvement showed limited concordance with pathological CRM status after NAT. Integration of MRF status and RAS status refines prognostic stratification in non-metastatic MRF-positive rectal cancer, guiding subsequent treatment decisions.Keywords
This publication has 34 references indexed in Scilit:
- Preoperative Magnetic Resonance Imaging Assessment of Circumferential Resection Margin Predicts Disease-Free Survival and Local Recurrence: 5-Year Follow-Up Results of the MERCURY StudyJournal of Clinical Oncology, 2014
- Rectal cancerStrahlentherapie und Onkologie, 2013
- Rectal Cancer: MR imaging of the mesorectal fascia and effect of chemoradiation on assessment of tumor involvementJournal of Magnetic Resonance Imaging, 2012
- Locally Advanced Rectal Cancer: Added Value of Diffusion-weighted MR Imaging for Predicting Tumor Clearance of the Mesorectal Fascia after Neoadjuvant Chemotherapy and Radiation TherapyRadiology, 2011
- Mesorectal Fascia Instead of Circumferential Resection Margin in Preoperative Staging of Rectal CancerJournal of Clinical Oncology, 2011
- Magnetic resonance imaging cannot predict histological tumour involvement of a circumferential surgical margin in rectal cancerColorectal Disease, 2010
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesThe Lancet, 2007
- The clinical significance of the circumferential resection margin following preoperative pelvic chemo‐radiotherapy in rectal cancer: why we need a common languageColorectal Disease, 2006
- Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational studyBMJ, 2006
- Rectal Cancer: Review with Emphasis on MR ImagingRadiology, 2004